JAMESBURG, N.J., July 26 /PRNewswire/ -- Phytomedics Inc., an innovative biopharmaceutical company focused on the discovery, development, and manufacture of novel botanical therapeutics, announced today that it has enlisted industry veteran Arthur H. Finnel to be its chief financial officer.
Mr. Finnel’s background encompasses significant achievements across a group of industries, including biotechnology, food and agriculture, and consumer products. He has considerable experience working with both large and small companies and in developing early-stage businesses into later-stage enterprises. He also brings with him the benefit of a broad base of experience across an array of management functions through his tenures as financial vice president, CFO, and in general management positions.
“Art Finnel brings exactly the kind of experience we need to move Phytomedics Inc. forward to the next level of our development,” said Dr Bertold Fridlender, president and CEO of Phytomedics. “He is a most knowledgeable financial executive in the biotech / agribusiness field with extensive experience of public offerings and corporate partnerships on a global level. We are very happy to welcome him to the Phytomedics team.”
Mr. Finnel has more than thirty years of leadership experience with both public and privately held companies. Most recently, from 2005 through July 2007, Mr. Finnel was CFO of Wellgen Inc., a biotechnology company using nutrigenomics to discover and develop plant-based wellness products. From 1995 -- 2004, he was Executive Vice President, Treasurer and Chief Financial Officer of Bionova Holding Corporation, an agribusiness biotechnology company. Among other achievements there, he managed its acquisition by Savia S.A. de C. V. and its initial public offering in 1996. Prior to joining Bionova, Mr. Finnel held senior executive positions of increasing responsibility from 1982 through 1995 at Mars Incorporated, the giant global food company.
Mr. Finnel holds three degrees from the University of Pennsylvania -- a Bachelor of Science degree in Economics from the Wharton School , a Master’s Degree in Operations Research, and a Wharton MBA in Finance.
About Phytomedics Inc.
Phytomedics Inc. (www.phytomedics.com) uses a broad and innovative proprietary technology platform to discover, develop, manufacture, and commercialize novel, multi-component and multi-functional botanical therapeutics. Founded by Professor Ilya Raskin, Ph.D., the company’s Chief Scientific Officer, Phytomedics Inc. conducts most of its research at the Biotech Center of Rutgers University.
Phytomedics Inc.
CONTACT: Ira S. Pastor, VP Business Development of Phytomedics Inc.,+1-609-655-0715, pastor@phytomedics.com
Web site: http://www.phytomedics.com/
